Heramed (ASX:HMD) — Material Events
ASX:HMD · 11 articles in the last 12 months · 100% assessed
Click a band to jump to that tier
Major ≥90
Significant 75–89
Notable 50–74
Routine <50
Not assessed
HeraMED Secures $1.98M, Nears Key U.S. Deals, and Advances AI Maternity TechMedium
HeraMED raises $1.98M, advances U.S. commercial deals, and expands AI maternity care platform
31 Oct 2025
·Quarterly Activities & Cashflow Report
·85
HeraMED’s HeraBEAT Secures Exclusive TGA Class IIb Approval in AustraliaMedium
HeraMED's HeraBEAT gains exclusive Class IIb TGA approval, unlocking Australian market opportunity
20 Nov 2025
·Regulatory Announcement
·85
HeraMED Accelerates US Entry with Philips Deal and Aussie Regulatory WinMedium
HeraMED secures US commercial deals, achieves Australian regulatory milestone, and raises $3.2M capital
30 Jan 2026
·Quarterly Activities & Cashflow Report
·85
HeraMED Teams with Philips to Revolutionize U.S. Digital Maternity CareMedium
HeraMED partners with Philips to launch digital maternity care solution in U.S.
25 Nov 2025
·Commercial Agreement
·80
HeraMED Accelerates AI Innovations to Transform Maternity Care by 2026Medium
HeraMED Accelerates AI Maternity Care Innovations with Early AI Clinician Assistant Launch
22 Sept 2025
·ASX Announcement
·80
HeraMED Launches US Pilot with Lee Health to Revolutionize Maternity CareMedium
HeraMED partners with Lee Health for US pilot of digital maternity care platform
27 Nov 2025
·Partnership Announcement
·80
HeraMED Secures $3.2M to Accelerate Digital Maternity Care ExpansionMedium
HeraMED raises $3.2M via discounted placement to accelerate global digital maternity care expansion
27 Jan 2026
·Capital Raising
·80
HeraMED Secures $1.98M to Accelerate Global Maternity Tech ExpansionMedium
HeraMED raises $1.98M via discounted placement to fund global maternity care expansion
4 Aug 2025
·Capital Raising
·75
HeraMED Boosts AI Maternity Care and US Growth Amid Policy ShiftsMedium
HeraMED advances AI maternity care partnerships, strengthens US growth team, reports Q2 cashflow and strategic progress
4 Aug 2025
·Quarterly Activities & Cashflow Report
·70
HeraMED Resumes Trading After Key Financial Disclosures and Capital RaiseMedium
HeraMED Limited reinstated to trading after quarterly reports and capital raising announcement
5 Aug 2025
·Reinstatement to Quotation
·70
BDO Audit Flags Going Concern Doubts in HeraMED’s H1 2025 ReviewMedium
BDO Audit issues unmodified review report with going concern uncertainty for HeraMED Limited H1 2025
28 Aug 2025
·Independent Auditor's Review Report
·50
No articles in this tier for the last 12 months.
Market Mentions
1
- appeared in market wrap coverage
These are market wrap articles where Heramed (ASX:HMD) was mentioned. They reflect broader market coverage, not company-specific announcements.
Healthcare Wrap - Week 5 (26 Jan -> 30 Jan) 2026
31 Jan 2026